Literature DB >> 17466034

Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany.

R Chekerov1, C Denkert, D Boehmer, A Suesse, A Widing, B Ruhmland, A Giese, A Mustea, W Lichtenegger, J Sehouli.   

Abstract

The concept of the online tumor conference was established in 2004 as a pilot project. We developed specific web-based software to organize and conduct online tumor board meetings of gynecologists, surgeons, radiologists, oncologists, and pathologists from different hospitals and gynecological practitioners, discussing individual patient's cases, defining therapy options, and exchanging clinical experience. Following a didactic approach, patient data are presented to the participants, with a special focus toward patient's preference and late toxicity from prior therapy. Then different national (eg, Arbeitsgemeinschaft Gynaekologische Onkologie, Deutsche Gesellschag fur Gynaekologic und Geburtshilfe) and international guidelines (eg, American Society of Clinical Oncology, National Cancer Institute), current study results based on literature review and open clinical trials are discussed. An individual diagnosis and therapy recommendation for each patient is reached by consensus. All protocols, guidelines, and publication data are upgraded and dispersed via Internet for all participants. In the period from December 2004 to August 2006, 39 tumor board conferences were performed with a total of 667 participants. One hundred forty-four patients' cases were presented, and 121 peer-reviewed second-opinions were sought. In an anonymous survey, 84% of the participants reported to be satisfied with the information content and 72% with the technical support. Overall 98% of the individual therapy recommendations were accepted and implemented. The tumor board conference presents an optimal possibility for extensive scientific discussions and exchange (92%) and improves advanced educational training (81%). In conclusion, the online tumor conference is feasible and represents a time-saving possibility for gynecological oncologist to receive a treatment recommendation based on the best available clinical and scientific evidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466034     DOI: 10.1111/j.1525-1438.2007.00971.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  12 in total

1.  Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature.

Authors:  J M Croke; S El-Sayed
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

2.  Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health Study.

Authors:  Kevin S Scher; Diana M Tisnado; Danielle E Rose; John Lloyd Adams; Clifford Y Ko; Jennifer L Malin; Patricia A Ganz; Katherine L Kahn
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

3.  An online tumor board with international neurosurgical collaboration guides surgical decision-making in Western Kenya.

Authors:  Fraser Henderson; Jacob Lepard; Jason Seibly; William Rambo; Scott Boswell; William R Copeland
Journal:  Childs Nerv Syst       Date:  2020-06-22       Impact factor: 1.475

4.  TELEHEALTH ALLOWS FOR CLINICAL TRIAL PARTICIPATION AND MULTIMODALITY THERAPY IN A RURAL PATIENT WITH STAGE 4 NON-SMALL CELL LUNG CANCER.

Authors:  James M Clark; Laurence J Heifetz; Daphne Palmer; Lisa M Brown; David T Cooke; Elizabeth A David
Journal:  Cancer Treat Res Commun       Date:  2016

Review 5.  Medicolegal Considerations in Multidisciplinary Cancer Care.

Authors:  Pamela L Karas; Nicole M Rankin; Emily Stone
Journal:  JTO Clin Res Rep       Date:  2020-07-03

6.  [Patient-centered care. Improvement of communication between university medical centers and general practitioners for patients in neuro-oncology].

Authors:  M Renovanz; N Keric; C Richter; A Gutenberg; A Giese
Journal:  Nervenarzt       Date:  2015-12       Impact factor: 1.214

7.  Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.

Authors:  Lindsay Kuroki; Ashley Stuckey; Priya Hirway; Christina A Raker; Christina A Bandera; Paul A DiSilvestro; Cornelius O Granai; Robert D Legare; Bachir J Sakr; Don S Dizon
Journal:  Gynecol Oncol       Date:  2009-12-29       Impact factor: 5.482

8.  Evaluating the use of telemedicine in gynaecological practice: a systematic review.

Authors:  Sughashini Murugesu; Nicolas Galazis; Benjamin P Jones; Maxine Chan; Timothy Bracewell-Milnes; Yousra Ahmed-Salim; Karen Grewal; Dirk Timmerman; Joseph Yazbek; Tom Bourne; Srdjan Saso
Journal:  BMJ Open       Date:  2020-12-07       Impact factor: 2.692

9.  Challenges in multidisciplinary cancer care among general surgeons in Canada.

Authors:  Anna R Gagliardi; Frances C Wright; Dave Davis; Robin S McLeod; David R Urbach
Journal:  BMC Med Inform Decis Mak       Date:  2008-12-22       Impact factor: 2.796

10.  Status of radiotherapy in a multidisciplinary cancer board.

Authors:  Mayumi Ichikawa; Kenji Nemoto; Misako Miwa; Ibuki Ohta; Takuma Nomiya; Mayumi Yamakawa; Yuriko Itho; Tadahisa Fukui; Takashi Yoshioka
Journal:  J Radiat Res       Date:  2013-08-26       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.